Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 35,000 shares at $70.34 ($2.5M) on 2021-10-11, disclosed to the SEC on 2021-10-13.
Open-market sale of $2.5M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.09 | 13,453 | $943K | 38.4% |
| 2 | $70.09 | 13,453 | $943K | 38.4% |
| 3 | $70.34 | 4,047 | $285K | 11.6% |
| 4 | $70.34 | 4,047 | $285K | 11.6% |
| Total | $70.15 avg | 35,000 | $2.5M | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |